Earnings History Data for BridgeBio Pharma (BBIO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
BridgeBio Pharma
BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | PM | BBIO | BridgeBio Pharma | 5,094 | -0.86 | -1.03 | 0.00 | BridgeBio Pharma GAAP EPS of -$0.86 beats by $0.09, revenue of $2.73M misses by $0.65M [11/12/2024 7:59 AM] |
24.64 | -1.48 (-5.67%) |
25.81 | -0.31 (-1.19%) |
21.62 - 44.32 | 1,875,238 | 1,490,000 | 7,407 | ||
| 05-08-2021 | PM | BBIO | Bridgebio Pharma, Inc. | 7,881 | -0.66 | -0.93 | 0.00 | BridgeBio Pharma EPS beats by $0.31, beats on revenue [8/5/2021 8:54 AM] |
56.13 | 3.31 (6.26%) |
52.83 | 0.0 (0.00%) |
26.81 - 73.50 | 562,993 | 760,000 | 115,833 | ||
|
||||||||||||||||||
| 06-05-2021 | PM | BBIO | Bridgebio Pharma, Inc. | 8,061 | -1.18 | -0.87 | 0.00 | BridgeBio Pharma EPS misses by $0.37 [5/6/2021 8:01 AM] |
49.59 | -3.35 (-6.33%) |
49.59 | 0.0 (0.00%) |
26.17 - 73.50 | 1,543,727 | 540,000 | 1,186 | ||
| 05-11-2020 | PM | BBIO | BridgeBio Pharma, Inc. | 4,890 | -0.98 | -0.97 | -0.51 | BridgeBio Pharma EPS misses by $0.01, misses on revenue [11/5/2020 7:48 AM] |
40.99 | 0.97 (2.42%) |
40.99 | 0.0 (0.00%) |
14.23 - 48.36 | 655,503 | 542,633 | 4,376 | ||
|
|
||||||||||||||||||
| 11-08-2020 | PM | Before the open (Aug 11) |
BBIO | BridgeBio Pharma, Inc. | 3,460 | -1.03 | -0.79 | 0.00 | BridgeBio Pharma EPS misses by $0.23 [8/11/2020 7:47 AM] |
29.11 | 0.22 (0.76%) |
28.89 | 0.0 (0.00%) |
14.23 - 48.36 | 177,264 | 425,951 | 53,667 | |
|
|
||||||||||||||||||